- Home
- PINC vs SPRY Comparison
PINC vs SPRY Comparison
Compare PINC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINC
- SPRY
- Stock Information
- Founded
- PINC 2013
- SPRY 2015
- Country
- PINC United States
- SPRY United States
- Employees
- PINC N/A
- SPRY N/A
- Industry
- PINC Other Consumer Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- PINC Consumer Discretionary
- SPRY Health Care
- Exchange
- PINC Nasdaq
- SPRY Nasdaq
- Market Cap
- PINC 1.8B
- SPRY 1.8B
- IPO Year
- PINC 2013
- SPRY N/A
- Fundamental
- Price
- PINC $27.90
- SPRY $10.31
- Analyst Decision
- PINC Hold
- SPRY Strong Buy
- Analyst Count
- PINC 6
- SPRY 5
- Target Price
- PINC $26.08
- SPRY $31.00
- AVG Volume (30 Days)
- PINC 2.2M
- SPRY 3.0M
- Earning Date
- PINC 11-04-2025
- SPRY 11-12-2025
- Dividend Yield
- PINC 3.01%
- SPRY N/A
- EPS Growth
- PINC N/A
- SPRY N/A
- EPS
- PINC 0.22
- SPRY N/A
- Revenue
- PINC $1,012,647,000.00
- SPRY $112,339,000.00
- Revenue This Year
- PINC N/A
- SPRY N/A
- Revenue Next Year
- PINC $2.70
- SPRY $188.92
- P/E Ratio
- PINC $41.03
- SPRY N/A
- Revenue Growth
- PINC N/A
- SPRY 22367.80
- 52 Week Low
- PINC $17.23
- SPRY $9.34
- 52 Week High
- PINC $28.79
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- PINC 65.43
- SPRY 41.76
- Support Level
- PINC $27.76
- SPRY $9.72
- Resistance Level
- PINC $27.85
- SPRY $10.99
- Average True Range (ATR)
- PINC 0.38
- SPRY 0.59
- MACD
- PINC -0.05
- SPRY 0.28
- Stochastic Oscillator
- PINC 83.41
- SPRY 57.52
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.